Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the Treatment of Brain Tumors

Despite intensive efforts to improve multimodal treatment of brain tumors, survival remains limited. Current therapy consists of a combination of surgery, irradiation and chemotherapy with predisposition to long-term complications. Identifying novel targeted therapies is therefore at the forefront o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keir, Stephen T., Dewhirst, Mark W., Kirkpatrick, John P., Bigner, Darell D., Batinic-Haberle, Ines
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3357315/
https://ncbi.nlm.nih.gov/pubmed/21291403
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares